Related Experiment Video

Updated: Aug 15, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer

Alex Lyakhovich1, Jordi Surralles

  • 1Group of Mutagenesis, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.

Cancer Letters
|October 26, 2005
PubMed

Insights

Disruptions in the Fanconi anemia/BRCA (FA/BRCA) pathway are linked to sporadic cancers, suggesting these cancers may respond well to DNA cross-linking therapies. Research explores how FA/BRCA pathway disruptions drive cancer development and treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Fanconi anemia/BRCA (FA/BRCA) pathway is crucial for DNA repair, particularly in response to interstrand cross-links.
  • Growing evidence links disruptions in this pathway to the development of various sporadic cancers.
  • Understanding these links is vital for predicting treatment responses and developing new therapeutic strategies.

Purpose of the Study:

  • To review and expand upon the known mechanisms linking FA/BRCA pathway disruption to sporadic cancers.
  • To explore the upstream and downstream events associated with FA/BRCA pathway dysfunction in cancer.
  • To highlight the potential of targeting the FA/BRCA pathway in cancer treatment.

Main Methods:

  • Literature review of studies investigating the FA/BRCA pathway in sporadic cancers.
  • Analysis of mechanisms including epigenetic silencing, gene mutations, and product modifications.
  • Synthesis of findings to connect pathway disruption to cancer occurrence, development, and treatment.

Main Results:

  • FA/BRCA pathway disruption can occur through various mechanisms, including epigenetic silencing of key genes (e.g., FA-core complex, BRCA1/2).
  • Mutations in FA-BRCA genes or alterations in their encoded products are also implicated in sporadic cancer.
  • These disruptions create a cellular environment conducive to cancer initiation and progression.

Conclusions:

  • Disruption of the FA/BRCA pathway is a significant factor in sporadic cancer development.
  • Cancers with FA/BRCA pathway defects are potential candidates for DNA cross-linking chemotherapy.
  • Further research into FA/BRCA pathway alterations is warranted for improved cancer treatment strategies.

More Related Videos

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...